These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4796839)

  • 1. Antagonism of the effects of delta 9-tetrahydrocannabinol by pemoline (Cylert-4).
    Howes JF
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):901-8. PubMed ID: 4796839
    [No Abstract]   [Full Text] [Related]  

  • 2. General and behavioral pharmacology.
    Harris LS
    Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947
    [No Abstract]   [Full Text] [Related]  

  • 3. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulant activity of pemoline and magnesium hydroxide.
    Plotnikoff N; Will F; Ditzler W
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):441-58. PubMed ID: 4397542
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology of marihuana.
    Forney RB
    Pharmacol Rev; 1971 Dec; 23(4):279-84. PubMed ID: 4943946
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of cannabis on the conditioned alimentary motor reflex in cats.
    Navrátil J; Medek A; Hrbek J; Krejcí Z; Komenda S; Dvorák M
    Act Nerv Super (Praha); 1972; 14(2):109-10. PubMed ID: 5040148
    [No Abstract]   [Full Text] [Related]  

  • 7. [Group toxicity and autoaggressivity induced by 5-phenyl-2-imino-4-oxo-oxazolidine (pemoline)].
    Genovese E; Napoli PA; Bolego Zonta N
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1953-7. PubMed ID: 5753841
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alkylans-alkylandum reactions. 11. The anti-alkylant effect of 5-phenyl-2-imino-4-oxazolidone (pemoline)].
    Rauen HM; Schriewer H; Ferié F
    Arzneimittelforschung; 1972 Dec; 22(12):2069-70. PubMed ID: 4679172
    [No Abstract]   [Full Text] [Related]  

  • 10. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
    Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
    Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of delta9 tetrahydrocannabinol on amphetamine induced lethality in aggregated mice.
    Howes JF
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):895-900. PubMed ID: 4760896
    [No Abstract]   [Full Text] [Related]  

  • 12. Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents.
    Dewey WL; Harris LS; Kennedy JS
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):133-45. PubMed ID: 5059359
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
    Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
    Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemoline: enhancement of maze performance in young rats.
    Plotnikoff NP
    Behav Biol; 1973 Jul; 9(1):117-21. PubMed ID: 4731942
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of magnesium pemoline in dimethylsulfoxide on reversal learning, motor activity, and water intake.
    Boitano JJ; Patrissi GA; Simone SA
    Psychol Rep; 1971 Feb; 28(1):71-9. PubMed ID: 5552765
    [No Abstract]   [Full Text] [Related]  

  • 16. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives.
    Domino EF; Hardman HF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):317-36. PubMed ID: 5003209
    [No Abstract]   [Full Text] [Related]  

  • 17. Central action of sanumgerman in mice.
    Kleinrok Z; Lekim D; Jagiełło-Wójtowicz E; Chodkowska A
    Pol J Pharmacol Pharm; 1986; 38(3):299-307. PubMed ID: 3774627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and toxicological study of a new psychotropic stimulant: the 2-phenyl-5-dimethyl-tetrahydro-1,4-oxazine, in comparison with d,l-amphetamine, phenmetrazine and pemoline-Mg.
    Fanelli O
    Arzneimittelforschung; 1973 Jun; 23(6):810-6. PubMed ID: 4740767
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
    Marchese G; Casu G; Casti P; Spada GP; Pani L
    Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.